A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity
Abstract Intravitreal Conbercept (IVC) is the latest applied and effective treatment for the management of retinopathy of prematurity (ROP). However, conbercept escapes from the vitreous into the general circulation and reduce systemic VEGF concentrations. Thus, there are concerns about systemic com...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/2a6976448096415bb298f7741443f4aa |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|